Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.

Ghavamzadeh, A; Alimoghadam, K; Nasseri, P; Jahani, M; Khodabandeh, A; Ghahremani, G

Ghavamzadeh, A; Alimoghadam, K; Nasseri, P; Jahani, M; Khodabandeh, A; Ghahremani, G.

Affiliation

Ghavamzadeh A; Department of Oncology, Shariati Hospital, Tehran University of Medical Science, Iran.

Bone Marrow Transplant ; 23(3): 299-301, 1999 Feb.

Article in En | MEDLINE | ID: mdl-10084264

Subject(s)

Anemia, Aplastic/therapy; Bone Marrow Transplantation; Dyskeratosis Congenita/complications; Adolescent; Adult; Anemia, Aplastic/etiology; Bone Marrow Transplantation/adverse effects; Busulfan; Chronic Disease; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Dyskeratosis Congenita/genetics; Erythema/etiology; Esophageal Stenosis/etiology; Female; Follow-Up Studies; Graft vs Host Disease/diagnosis; Graft vs Host Disease/etiology; Humans; Immunosuppressive Agents/therapeutic use; Male; Nuclear Family; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Transplantation / Dyskeratosis Congenita / Anemia, Aplastic Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 1999 Type: Article Affiliation country: Iran

Search on Google

XML

PubMed Links